| 2025 | Invention | Method of administration and treatment. 
Provided herein are formulations for topical and/or tran... | 
				    			
				    				
				    					| 2024 | Invention | Buffering for non-alcoholic steatohepatitis and liver diseases. 
The present disclosure relates t... | 
				    			
				    				
				    					|  | Invention | Formulations for transdermal administration of active agents. 
The present disclosure relates to ... | 
				    			
				    				
				    					|  | Invention | Transdermal carrier. 
Improved formulations for topical treatment that ensure at least localized ... | 
				    			
				    				
				    					|  | Invention | Methods for treating gout and bone decalcification. 
The present disclosure relates to transderma... | 
				    			
				    				
				    					|  | Invention | Methods for treating inflammatory pain and bone decalcification. 
The present disclosure relates ... | 
				    			
				    				
				    					| 2023 | Invention | Transdermal penetrant formulations for administration of medicaments. 
The present disclosure rel... | 
				    			
				    				
				    					|  | Invention | Method of administration and treatment. Provided herein are formulations for topical and/or trans... | 
				    			
				    				
				    					|  | Invention | Buffering for non-alcoholic steatohepatitis and liver diseases. e.g.,e.g., a non-alcoholic fatty ... | 
				    			
				    				
				    					|  | Invention | Formulations for transdermal administration of active agents. The present disclosure relates to a... | 
				    			
				    				
				    					| 2022 | Invention | Methods for treating inflammation and bone density disorder by transdermally administering buffer... | 
				    			
				    				
				    					|  | Invention | Methods for treating gout and bone decalcification by transdermally administering buffering agent... | 
				    			
				    				
				    					|  | Invention | Transdermal carrier. Improved formulations for topical treatment that ensure at least localized t... | 
				    			
				    				
				    					|  | Invention | Topical delivery of buffering agents for prevention and treatment of viral infections. 
Provided ... | 
				    			
				    				
				    					|  | Invention | Topical cyclosporine for treating psoriasis and other ailments. 
Disclosed herein is a transderma... | 
				    			
				    				
				    					|  | Invention | Transdermal penetration by modulating epithelial junctions. 
Embodiments include a transdermal de... | 
				    			
				    				
				    					|  | Invention | Transdermal penetrant formulations for administration of medicaments. The present disclosure rela... | 
				    			
				    				
				    					|  | Invention | Transdermal formulations for phosphodiesterase-5 inhibitors. The present disclosure relates to a ... | 
				    			
				    				
				    					| 2021 | Invention | Transdermal penetrant formulations. 
Disclosed herein is a transdermal delivery formulation for t... | 
				    			
				    				
				    					|  | Invention | Inhibition of spontaneous metastasis via protein inhibitors of cysteine proteases. 
Two disparate... | 
				    			
				    				
				    					|  | Invention | Topical delivery of buffering agents for prevention and treatment of viral infections. Provided h... | 
				    			
				    				
				    					| 2020 | Invention | Transdermal penetrant formulations containing cannabidiol. 
Disclosed herein is a transdermal del... | 
				    			
				    				
				    					| 2019 | Invention | Management of risk of cation overload and electrolyte imbalance with topically applied buffers. 
... | 
				    			
				    				
				    					|  | Invention | Methods and formulations for transdermal administration of dermal contouring agents. 
Disclosed h... | 
				    			
				    				
				    					|  | Invention | Formulations and methods for transdermal administration of ketones. 
A formulation for transderma... | 
				    			
				    				
				    					|  | Invention | Iron formulations for topical administration and methods of treatment of iron deficiency. 
Provid... | 
				    			
				    				
				    					|  | Invention | Transdermal penetrant formulations containing cannabidiol. Disclosed herein is a transdermal deli... | 
				    			
				    				
				    					| 2018 | Invention | Topical applications of withaferin a. 
This disclosure is directed to the topical/transdermal adm... | 
				    			
				    				
				    					|  | Invention | Methods and formulations for transdermal administration of buffering agents. 
A formulation for t... | 
				    			
				    				
				    					| 2017 | Invention | Enhanced transdermal delivery of active agents. 
Improved formulations that combine chemical perm... | 
				    			
				    				
				    					| 2015 | Invention | Methods and formulations for transdermal administration. 
Improved formulations for topical treat... |